Clinical Trial Update: Chronic Graft-Versus-Host Disease in Patients Who Have Undergone Donor Stem Cell Transplant

View source ↗

Summary

A clinical trial evaluating chronic graft-versus-host disease after allogeneic donor stem cell transplantation in cancer patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Graft-versus-host Disease

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Cancer | Status: TERMINATED